Poland· PL-100440894

Fingolimod +pharma

A fingolimod product containing fingolimodum, registered in Poland by +pharma arzneimittel GmbH. The same ATC class is registered in 16 of our 19 countries.

ATC L04AE01

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about fingolimodumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Fingolimod is registered in 16 of 19 countries.

Countries holding a registration under ATC L04AE01 (fingolimod), each read from that country’s own register.

This record: Poland, from URPL (Poland)
9 of them publish a price we can compare per daily dose

Search fingolimod products by name

Fingolimod · ATC L04AE01

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fingolimod costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Fingolimod · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

IT Italy$27.25
CH Switzerland$18.53

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Fingolimodum
Manufacturer: +pharma arzneimittel GmbH
Country: Poland (PL)
ATC code: L04AE01
ATC class: Fingolimod
Defined daily dose: 0.5 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 9

gtin
05901720140647
gtin
05901720140609
gtin
05901720140678
gtin
05901720140623
gtin
05901720140630
gtin
05901720140661
gtin
05901720140616
gtin
05901720140593
gtin
05901720140654

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

584 interactions on record for fingolimod.

Graded by severity as the source publishes them — 503 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check fingolimod against other medicines How interaction checks work

Fingolimod · interactions on record

584 records

503 severe
77 moderate
4 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fingolimod in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fingolimod products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Areleptan, Chantico
Belgium · Fingolimod Ab, Fingolimod Eg
Bulgaria · Chantico, Inzolfi
Cyprus · Fingolimod Adelco, Fingolimod Remedica
Czechia · Areleptan, Bonaxon
Germany · Fingod, Fingolimod 123 Acurae Pharma
Denmark · Areleptan, Bonaxon
Estonia · Chantico, Efigalo
Spain · Fingolimod, Fingolimod Aurovitas
Finland · Fingolimod, Fingolimod Avansor
France · Fingolimod Arrow, Fingolimod Benta
United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
Greece · Fingolimod Adelco, Fingolimod Medochemie
Croatia · Areleptan, Arlesias
Hungary · Bonaxon, Chantico
Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
Iceland · Fingolimod, Fingolimod Accord
Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
Liechtenstein · Fingolimod Accord, Fingolimod Mylan
Lithuania · Chantico, Efigalo
Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
Latvia · Bonaxon, Chantico
Malta · Fingolimod Denk, Fingolimod Remedica
Netherlands · Chantico, Fenoxa
Norway · Areleptan, Fingolimod Accord
Portugal · Bluesar, Fingolimod Bluefish
Romania · Fingolimod Dr. Reddys, Fingolimod Msn
Sweden · Areleptan, Fingolimod Amarox
Slovenia · Areleptan, Arlesias
Slovakia · Areleptan, Bonaxon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/218e4bb5-1bf4-47bb-abd0-74dbc6f772d8
GET /v1/drugs/218e4bb5-1bf4-47bb-abd0-74dbc6f772d8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "0,5 mg",
  "packaging": "05901720140647 ¦ Rpz ¦ 143191\n30 kaps.\n05901720140609 ¦ Rpz ¦ 143890\n7 kaps. w blistrze perforowanym\n05901720140678 ¦ Rpz ¦ 143891\n100 kaps.\n05901720140623 ¦ Rpz ¦ 143892\n14 kaps.\n05901720140630 ¦ Rpz ¦ 143893\n28 kaps.\n05901720140661 ¦ Rpz ¦ 143894\n98 kaps.\n05901720140593 ¦ Rpz ¦ 143895\n7 kaps. w blistrze\n05901720140654 ¦ Rpz ¦ 143896\n84 kaps.\n05901720140616 ¦ Rpz ¦ 143897\n10 kaps.",
  "substance": "Fingolimodum 0.5 mg",
  "common_name": "Fingolimodum",
  "pl_product_id": "100440894",
  "pozwolenie_nr": "26924",
  "auth_procedure": "DCP",
  "authorisation_validity": "2027-02-15"
}

API reference MCP server Plans

See everything about fingolimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console